Gil Schwartzberg - Jun 30, 2021 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director, 10%+ Owner
Signature
/s/ Gil Schwartzberg
Stock symbol
LIXT
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 04:06 PM
Next filing
Feb 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIXT Option to Purchase Common Stock Award $0 +100K $0.00 100K Jun 30, 2021 Common 100K $3.03 Direct F1
holding LIXT Option to Purchase Common Stock 250K Jun 30, 2021 Common 250K $3.20 Direct F1
holding LIXT Warrant to Purchase Common Stock 105K Jun 30, 2021 Common 105K $5.70 Direct
holding LIXT Options to Purchase Common Stock 292K Jun 30, 2021 Common 292K $3.00 By Julie Schwartzberg Trust
holding LIXT Warrant to Purchase Common Stock 83.3K Jun 30, 2021 Common 83.3K $6.00 By Julie Schwartzberg Trust
holding LIXT Warrant to Purchase Common Stock 83.3K Jun 30, 2021 Common 83.3K $6.00 By David N. Sterling Trust
holding LIXT Options to Purchase Common Stock 83.3K Jun 30, 2021 Common 83.3K $3.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective June 30, 2021, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting in eight equal installments on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 20, 2021).